Clinical Trials

Showing trials with last updates posted in 2018.

NCT02681094 | COMPLETED | PHASE3
905 participants
NCT01900600 | COMPLETED | NA
15 participants

Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP)

Study Type:
INTERVENTIONAL
Last Updated:
2018-10-10
Start Date:
2013-04-30
Completion:
2015-01-08
Conditions
  • Prior Acute Myocardial Infarction
  • Evidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l)
  • Reduced Left Ventricle Ejection Fraction (<50%)
  • Symptoms of Heart Failure (NYHA Class II-III)
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page